Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Case ReportImages in Rheumatology

Cytomegalovirus Enteritis in a Patient with Rheumatoid Arthritis Receiving Baricitinib

Eri Sugawara, Kazuo Matsui and Yoshiharu Amasaki
The Journal of Rheumatology December 2020, 47 (12) 1835-1836; DOI: https://doi.org/10.3899/jrheum.191395
Eri Sugawara
Department of Rheumatology, Tonan Hospital, Sapporo, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eri Sugawara
  • For correspondence: e.sugawara@huhp.hokudai.ac.jp
Kazuo Matsui
Department of Rheumatology, Tonan Hospital, Sapporo, Japan.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiharu Amasaki
Department of Rheumatology, Tonan Hospital, Sapporo, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

T cells play a central role in immunity against cytomegalovirus (CMV)1. Baricitinib, a Janus kinase (JAK) inhibitor, suppresses T cell function by inhibiting JAK-signal transducers and activators of transcription (STAT)2. Interferon-γ (IFN-γ) is one of the major T cell cytokines involved in the immunity against CMV3. Tacrolimus has a strong inhibitory effect on IFN-γ as well as JAK inhibitors4.

A 65-year-old male with a 14-year history of rheumatoid arthritis (RA), who was treated with 12 mg/week of methotrexate (MTX) for 14 years, 4 mg of baricitinib, and 2 mg/day of tacrolimus for 6 months, presented abdominal pain and fever. Laboratory tests showed elevated C-reactive protein levels (1.7 mg/dl) and positive CMV antigenemia (102/50,000 cells). Computed tomography scan revealed a thickened distal ileum (Figure 1A). Total colonoscopy showed multiple ulcers in the terminal ileum (Figure 1B). Histopathologic examination revealed intranuclear inclusion bodies in the mucosa (Figure 1C), which were positive for CMV (Figure 1D), confirming CMV enteritis. After discontinuation of MTX and baricitinib, he was treated with intravenous ganciclovir for 2 weeks, followed by oral valganciclovir. MTX and baricitinib were readministered after antiviral therapy, while tacrolimus was discontinued. He experienced no flares of RA or CMV enteritis.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A. Abdominal computed tomography scan showing a thickened distal ileal segment with reactive fluid. B. Endoscopic image of the lower gastrointestinal tract, demonstrating multiple ulcers and erosive changes in the terminal ileum. C. Histologic examinations of the ulcers of the terminal ileum, showing ulcerative changes with inflammatory cell infiltration and cytomegalic changes with intranuclear and intracytoplasmic inclusion bodies in the vascular endothelium by H&E. D. In situ hybridization positive for cytomegalovirus.

Although MTX has been reported to be associated with CMV infection5, the patient had not experienced CMV infection despite the 14-year history of MTX treatment. Therefore, we hypothesize that CMV infection might have been accelerated mainly by strong T cell dysfunction induced by the combined effects of baricitinib and tacrolimus.

Acknowledgment

We thank the patient for his collaboration. The authors thank Yumiko Oyamada for pathologic diagnosis and Takeshi Uozumi for endoscopic diagnosis, as well as helpful discussion.

Footnotes

  • The present study was approved by the Ethics Committee of Tonan Hospital (approval No. 434), and written informed consent was obtained from the patient.

REFERENCES

  1. 1.↵
    1. Ozdemir E,
    2. St John LS,
    3. Gillespie G,
    4. Rowland-Jones S,
    5. Champlin RE,
    6. Molldrem JJ,
    7. et al.
    Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood 2002;100:3690–7.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Fridman JS,
    2. Scherle PA,
    3. Collins R,
    4. Burn TC,
    5. Li Y,
    6. Li J,
    7. et al.
    Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050. J Immunol 2010;184:5298–307.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Klenerman P,
    2. Oxenius A
    . T cell responses to cytomegalovirus. Nat Rev Immunol 2016;16:367–77.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Egli A,
    2. Kumar D,
    3. Broscheit C,
    4. O’Shea D,
    5. Humar A
    . Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. Transplantation 2013;95:448–55.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Ozaki T,
    2. Yamashita H,
    3. Kaneko S,
    4. Yorifuji H,
    5. Takahashi H,
    6. Ueda Y,
    7. et al.
    Cytomegalovirus disease of the upper gastrointestinal tract in patients with rheumatic diseases: a case series and literature review. Clin Rheumatol 2013;32:1683–90.
    OpenUrl
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 47, Issue 12
1 Dec 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cytomegalovirus Enteritis in a Patient with Rheumatoid Arthritis Receiving Baricitinib
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cytomegalovirus Enteritis in a Patient with Rheumatoid Arthritis Receiving Baricitinib
Eri Sugawara, Kazuo Matsui, Yoshiharu Amasaki
The Journal of Rheumatology Dec 2020, 47 (12) 1835-1836; DOI: 10.3899/jrheum.191395

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Cytomegalovirus Enteritis in a Patient with Rheumatoid Arthritis Receiving Baricitinib
Eri Sugawara, Kazuo Matsui, Yoshiharu Amasaki
The Journal of Rheumatology Dec 2020, 47 (12) 1835-1836; DOI: 10.3899/jrheum.191395
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Systemic Granulomatosis With Polyangiitis Presenting With Bilateral Renal Masses
  • Skin Eruption and Nerve Impairment: Eosinophil Activation Link
  • IgG4-Related Arterial Disease: An Unusual Case of Aortitis
Show more Images in Rheumatology

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire